Progetto Laser, lotta alla sepsi in Emilia-Romagna - apicella
Progetto Laser, lotta alla sepsi in Emilia-Romagna - apicella Progetto Laser, lotta alla sepsi in Emilia-Romagna - apicella
Progetto LaSER. Lotta alla sepsi in Emilia-Romagna Allegati • Trzeciak S., Dellinger R.P., Abate N.L., Cowan R.M., Stauss M., Kilgannon J.H., Zanotti S., Parrillo J.E. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest, 129 (2): 225-232, Feb 2006. PMID: 16478835 [PubMed - indexed for MEDLINE] • Wood K.A., Angus D.C. Pharmacoeconomic implications of new therapies in sepsis. Pharmacoeconomics, 22 (14): 895-906, 2004. Review. PMID: 15362927 [PubMed - indexed for MEDLINE] Dossier 143 68
Fluidoterapia Strategia di ricerca PubMed Progetto LaSER. Lotta alla sepsi in Emilia-Romagna Allegati (“Rehydration Solutions/administration and dosage”[MeSH] OR “Rehydration Solutions/adverse effects”[MeSH] OR “Rehydration Solutions/supply and distribution”[MeSH] OR “Rehydration Solutions/therapeutic use”[MeSH]) OR “Fluid Therapy”[MeSH] OR (“Fluid Therapy/adverse effects”[MeSH] OR “Fluid Therapy/methods”[MeSH] OR “Fluid Therapy/supply and distribution”[MeSH] OR “Fluid Therapy/utilization”[MeSH] OR crystalloid[text] OR crystalloid/blood[text] OR crystalloid/colloid[text] OR crystalloid/hespan[text] OR crystalloid/hydroxyethyl[text] OR crystalloid/saline[text] OR crystalloid’[text] OR crystalloidal[text] OR crystalloideight[text] OR crystalloides[text] OR crystalloids[text] OR crystalloidsalbumin[text] OR crystalloidstorage[text]) OR (colloid[text] OR colloid/adenomatous[text] OR colloid/blood[text] OR colloid/chemical[text] OR colloid/colloid[text] OR colloid/crystalloid[text] OR colloid/cystic[text] OR colloid/epithelial[text] OR colloid/gc[text] OR colloid/h2tmpyp/ths[text] OR colloid/hcl/bpy[text] OR colloid/hespan[text] OR colloid/hyperplastic[text] OR colloid/hypertonic[text] OR colloid/interstitial[text] OR colloid/ml[text] OR colloid/noncolloid[text] OR colloid/patent[text] OR colloid/polymer[text] OR colloid/ths/h2tmpyp[text] OR colloid’[text] OR colloid’s[text] OR colloid99mtc[text] OR colloidal[text] OR colloidal/bacterial[text] OR colloidal/immunoassay[text] OR colloidal/nano[text] OR colloidal’[text] OR colloidale[text] OR colloidalgold[text] OR colloidalis[text] OR colloidality[text] OR colloidall[text] OR colloidally[text] OR colloidalradioisotope[text] OR colloidals[text] OR colloidaly[text] OR colloide[text] OR colloides[text] OR colloidfree[text] OR colloidi[text] OR colloidial[text] OR colloidin[text] OR colloiding[text] OR colloidion[text] OR colloidization[text] OR colloidlike[text] OR colloidmilium[text] OR colloido[text] OR colloidochemical[text] OR colloidoclasia[text] OR colloidoclastic[text] OR colloidocystic[text] OR colloidocytosis[text] OR colloidogenic[text] OR colloidon[text] OR colloidoncotic[text] OR colloidoosmotic[text] OR colloidopathy[text] OR colloidopectic[text] OR colloidopexia[text] OR colloidopexic[text] OR colloidopexy[text] OR colloidophagic[text] OR colloidophagy[text] OR colloidorrhage[text] OR colloidosmostic[text] OR colloidosmotic[text] OR colloidosomes[text] OR colloidrhagia[text] OR colloids[text] OR colloids’[text] OR colloidsolution[text] OR colloidul[text]) AND (“Shock, Septic”[MeSH] OR “sepsis”[MeSH Terms]) AND (((“outcome and process assessment (health care)”[TIAB] NOT Medline[SB]) OR “outcome and process assessment (health care)”[MeSH Terms] OR Outcome and Process Assessment[Text Word]) OR (“clinical protocols”[MeSH Terms] OR Clinical Protocols[Text Word]) OR (“comparative study”[MeSH Terms] OR Comparative Study[Text Word]) OR (“practice guideline”[Publication Type] OR “practice guidelines”[MeSH Terms] OR “practice guideline”[Text Word]) OR (“controlled clinical trial”[Publication Type] OR “controlled clinical trials”[MeSH Terms] OR “controlled clinical trials”[Text Word]) OR (“randomized controlled trial”[Publication Type] OR “randomized controlled trials”[MeSH Terms] OR “randomized controlled trials”[Text Word]) OR (“meta-analysis”[Publication Dossier 143 69
- Page 20 and 21: Figura 2. Storia naturale della sep
- Page 22 and 23: Progetto LaSER. Lotta alla sepsi in
- Page 24 and 25: La sepsi Cause Progetto LaSER. Lott
- Page 27 and 28: Progetto LaSER. Lotta alla sepsi in
- Page 29 and 30: Progetto LaSER. Lotta alla sepsi in
- Page 31 and 32: Progetto LaSER. Lotta alla sepsi in
- Page 33 and 34: Progetto LaSER. Lotta alla sepsi in
- Page 35 and 36: 3.2. Diagnosi Progetto LaSER. Lotta
- Page 37 and 38: Progetto LaSER. Lotta alla sepsi in
- Page 39 and 40: 3.4. Antibioticoterapia Progetto La
- Page 41 and 42: Progetto LaSER. Lotta alla sepsi in
- Page 43 and 44: Progetto LaSER. Lotta alla sepsi in
- Page 45 and 46: Progetto LaSER. Lotta alla sepsi in
- Page 47 and 48: Progetto LaSER. Lotta alla sepsi in
- Page 49 and 50: Progetto LaSER. Lotta alla sepsi in
- Page 51 and 52: Progetto LaSER. Lotta alla sepsi in
- Page 53 and 54: Raccomandazione Progetto LaSER. Lot
- Page 55: Allegati Progetto LaSER. Lotta alla
- Page 58 and 59: Progetto LaSER. Lotta alla sepsi in
- Page 60 and 61: Tabella A.1. Risultati degli studi
- Page 62 and 63: Progetto LaSER. Lotta alla sepsi in
- Page 65 and 66: Allegato B. Glossario Progetto LaSE
- Page 67 and 68: Progetto LaSER. Lotta alla sepsi in
- Page 69: Progetto LaSER. Lotta alla sepsi in
- Page 73 and 74: Progetto LaSER. Lotta alla sepsi in
- Page 75 and 76: Progetto LaSER. Lotta alla sepsi in
- Page 77 and 78: Progetto LaSER. Lotta alla sepsi in
- Page 79 and 80: Progetto LaSER. Lotta alla sepsi in
- Page 81 and 82: Progetto LaSER. Lotta alla sepsi in
- Page 83 and 84: Progetto LaSER. Lotta alla sepsi in
- Page 85 and 86: Progetto LaSER. Lotta alla sepsi in
- Page 87 and 88: Progetto LaSER. Lotta alla sepsi in
- Page 89 and 90: Progetto LaSER. Lotta alla sepsi in
- Page 91 and 92: Progetto LaSER. Lotta alla sepsi in
- Page 93 and 94: Progetto LaSER. Lotta alla sepsi in
- Page 95 and 96: Progetto LaSER. Lotta alla sepsi in
- Page 97 and 98: Progetto LaSER. Lotta alla sepsi in
- Page 99 and 100: Proteina C attivata Strategia di ri
- Page 101: Progetto LaSER. Lotta alla sepsi in
- Page 104 and 105: Progetto LaSER. Lotta alla sepsi in
- Page 106 and 107: Progetto LaSER. Lotta alla sepsi in
- Page 109 and 110: COLLANA DOSSIER a cura dell’Agenz
- Page 111 and 112: 39. Rapporti tecnici della Task For
- Page 113 and 114: 82. Applicazione del DLgs 626/94 in
- Page 115: 125. Il clima organizzativo nelle A
<strong>Progetto</strong> LaSER. Lotta <strong>alla</strong> <strong>sepsi</strong> <strong>in</strong> <strong>Emilia</strong>-<strong>Romagna</strong><br />
Allegati<br />
• Trzeciak S., Dell<strong>in</strong>ger R.P., Abate N.L., Cowan R.M., Stauss M., Kilgannon J.H., Zanotti<br />
S., Parrillo J.E. Translat<strong>in</strong>g research to cl<strong>in</strong>ical practice: a 1-year experience with<br />
implement<strong>in</strong>g early goal-directed therapy for septic shock <strong>in</strong> the emergency department.<br />
Chest, 129 (2): 225-232, Feb 2006. PMID: 16478835 [PubMed - <strong>in</strong>dexed for MEDLINE]<br />
• Wood K.A., Angus D.C. Pharmacoeconomic implications of new therapies <strong>in</strong> <strong>sepsi</strong>s.<br />
Pharmacoeconomics, 22 (14): 895-906, 2004. Review. PMID: 15362927 [PubMed -<br />
<strong>in</strong>dexed for MEDLINE]<br />
Dossier 143<br />
68
Change language